These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2529423

  • 1. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M, Tajiri K, Taniya T, Kumaki T, Miyazaki I.
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [Abstract] [Full Text] [Related]

  • 2. Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7).
    Noguchi M, Tajiri K, Taniya T, Kumaki T, Ashikari A, Miyazaki I.
    Oncology; 1990 May; 47(1):19-24. PubMed ID: 2137212
    [Abstract] [Full Text] [Related]

  • 3. Effects of tamoxifen, medroxyprogesterone acetate and estradiol on tumor growth and oncogene expression in MCF-7 breast cancer cell line transplanted into nude mice.
    Mizukami Y, Tajiri K, Nonomura A, Noguchi M, Taniya T, Koyasaki N, Nakamura S, Matsubara F.
    Anticancer Res; 1991 May; 11(3):1333-8. PubMed ID: 1832273
    [Abstract] [Full Text] [Related]

  • 4. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J, Hui E, Ip T, Thompson LU.
    Clin Cancer Res; 2004 Nov 15; 10(22):7703-11. PubMed ID: 15570004
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
    Friedl A, Gottardis MM, Pink J, Buchler DA, Jordan VC.
    Cancer Res; 1989 Sep 01; 49(17):4758-64. PubMed ID: 2758409
    [Abstract] [Full Text] [Related]

  • 10. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ, Raney S.
    Cell Biol Int; 1998 Sep 01; 22(6):413-9. PubMed ID: 10328849
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice.
    Oka S, Kubota T, Takeuchi T, Kitajima M.
    J Surg Oncol; 1996 Apr 01; 61(4):256-61. PubMed ID: 8627994
    [Abstract] [Full Text] [Related]

  • 12. Hormonal therapy of human endometrial adenocarcinoma in a nude mouse model.
    Zaino RJ, Satyaswaroop PG, Mortel R.
    Cancer Res; 1985 Feb 01; 45(2):539-41. PubMed ID: 3967228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M.
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Steroid hormone receptors and response to high-dose medroxyprogesterone acetate in advanced breast cancer.
    Nomura Y, Tashiro H, Hisamatsu K, Shinozuka K.
    Anticancer Res; 1988 Nov 20; 8(4):647-51. PubMed ID: 2972248
    [Abstract] [Full Text] [Related]

  • 19. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 20; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 20. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB, Miron P, Miron A, Iglehart JD.
    J Surg Res; 2007 Mar 20; 138(1):37-44. PubMed ID: 17109887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.